<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JDM</journal-id>
<journal-id journal-id-type="hwp">spjdm</journal-id>
<journal-title>Journal of Diagnostic Medical Sonography</journal-title>
<issn pub-type="ppub">8756-4793</issn>
<issn pub-type="epub">1552-5430</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/8756479312460508</article-id>
<article-id pub-id-type="publisher-id">10.1177_8756479312460508</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Literature Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>JDMS</italic> CME Article-SDMS CME Credit</article-title>
</title-group>
<pub-date pub-type="epub-ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<volume>28</volume>
<issue>5</issue>
<fpage>231</fpage>
<lpage>232</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">Society of Diagnostic Medical Sonography</copyright-holder>
</permissions>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September/October 2012</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>Article: Comparison of Endobronchial Ultrasound and Computed Tomography With Fluoroscopy in the Guidance of Lung Cancer Biopsies: A Literature Review</p>
<p>Authors: Dora DiGiacinto, MEd, RDMS, RDCS</p>
<p>Jennifer Bagley, MPH, RDMS, RVT</p>
<p>Miranda Garrison, BSMIRS, RDMS</p>
<p>Category: Abdomen</p>
<p>Credit: 1 SDMS CME Credit</p>
<p>Objectives: After studying the article entitled “Comparison of Endobronchial Ultrasound and Computed Tomography With Fluoroscopy in the Guidance of Lung Cancer Biopsies: A Literature Review,” you will be able to:</p>
<list id="list1-8756479312460508" list-type="order">
<list-item><p>Describe the techniques and equipment used for ultrasound-guided endobronchial lung biopsies</p></list-item>
<list-item><p>Describe the sonographic image characteristics of lung lesions</p></list-item>
<list-item><p>Discuss the relative advantages and limitations of ultrasound-guided endobronchial lung biopsies versus guidance using computed tomography (CT) with fluoroscopy</p></list-item>
</list>
<list id="list2-8756479312460508" list-type="order">
<list-item><p>The median survival of patients following diagnosis of lung cancer is
<list id="list3-8756479312460508" list-type="alpha-lower">
<list-item><p>1–2 months</p></list-item>
<list-item><p>3–6 months</p></list-item>
<list-item><p>6–12 months</p></list-item>
<list-item><p>12–18 months</p></list-item>
</list></p>
</list-item>
<list-item><p>The most important predictor for the resectability and prognosis for lung cancer is
<list id="list4-8756479312460508" list-type="alpha-lower">
<list-item><p>Accurate staging</p></list-item>
<list-item><p>Lesion size</p></list-item>
<list-item><p>Lesion location</p></list-item>
<list-item><p>Lesion proximity to trachea</p></list-item>
</list></p>
</list-item>
<list-item><p>The gold standard to diagnose lung cancer is
<list id="list5-8756479312460508" list-type="alpha-lower">
<list-item><p>Endobronchial biopsy</p></list-item>
<list-item><p>Ultrasound-guided endobronchial biopsy</p></list-item>
<list-item><p>CT with fluoroscopy-guided biopsy</p></list-item>
<list-item><p>Open biopsy</p></list-item>
</list></p>
</list-item>
<list-item><p>Sonographically, a lung cancer lesion will appear
<list id="list6-8756479312460508" list-type="alpha-lower">
<list-item><p>As a dark, homogeneous structure</p></list-item>
<list-item><p>As a dark, heterogeneous structure</p></list-item>
<list-item><p>As a bright, heterogeneous structure</p></list-item>
<list-item><p>As a bright structure with a “snowstorm” appearance</p></list-item>
</list></p>
</list-item>
<list-item><p>The diagnostic yield for ultrasound-guided endobronchial lung cancer biopsy for lesions larger than 20 mm in size is typically
<list id="list7-8756479312460508" list-type="alpha-lower">
<list-item><p>&gt;50%</p></list-item>
<list-item><p>&gt;70%</p></list-item>
<list-item><p>&gt;85%</p></list-item>
<list-item><p>&gt;95%</p></list-item>
</list></p>
</list-item>
<list-item><p>The highest accuracy for ultrasound-guided endobronchial lung cancer biopsy occurs for lesions in the
<list id="list8-8756479312460508" list-type="alpha-lower">
<list-item><p>Left upper lobe</p></list-item>
<list-item><p>Left lower lobe</p></list-item>
<list-item><p>Right upper lobe</p></list-item>
<list-item><p>Right middle lobe</p></list-item>
</list></p>
</list-item>
<list-item><p>Ultrasound-guided transbrachial biopsies are typically done using a transducer operating at
<list id="list9-8756479312460508" list-type="alpha-lower">
<list-item><p>30 MHz</p></list-item>
<list-item><p>20 MHz</p></list-item>
<list-item><p>10 MHz</p></list-item>
<list-item><p>5 MHz</p></list-item>
</list></p>
</list-item>
<list-item><p>The most common complication reported for ultrasound-guided endobronchial lung cancer biopsies is
<list id="list10-8756479312460508" list-type="alpha-lower">
<list-item><p>Pneumothorax</p></list-item>
<list-item><p>Pleural effusion</p></list-item>
<list-item><p>Bleeding</p></list-item>
<list-item><p>Hemoptysis</p></list-item>
</list></p>
</list-item>
<list-item><p>The diagnostic yield for CT with fluoroscopy-guided lung cancer biopsies is typically
<list id="list11-8756479312460508" list-type="alpha-lower">
<list-item><p>85%–95%</p></list-item>
<list-item><p>75%–85%</p></list-item>
<list-item><p>65%–75%</p></list-item>
<list-item><p>55%–65%</p></list-item>
</list></p>
</list-item>
<list-item><p>The overall reported complication rate for CT with fluoroscopy-guided lung cancer biopsies is approximately
<list id="list12-8756479312460508" list-type="alpha-lower">
<list-item><p>3%</p></list-item>
<list-item><p>5%</p></list-item>
<list-item><p>8%</p></list-item>
<list-item><p>11%</p></list-item>
</list></p>
</list-item>
</list>
</body>
<back>
<bio>
<p><graphic id="img1-8756479312460508" position="anchor" xlink:href="10.1177_8756479312460508-img1.tif"/></p>
</bio>
</back>
</article>